Sign Up to like & get
recommendations!
1
Published in 2018 at "Behavioural Brain Research"
DOI: 10.1016/j.bbr.2017.11.015
Abstract: HIGHLIGHTSGSK‐3&bgr; is involved in the physiological and pathological progress of DM and AD respectively.In DM, GSK‐3&bgr; is one of the key factors leading to insulin deficiency and insulin resistance.In AD, GSK‐3&bgr; plays an important role…
read more here.
Keywords:
insulin;
gsk bgr;
bgr;
potential link ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "European Journal of Pharmacology"
DOI: 10.1016/j.ejphar.2017.03.028
Abstract: Abstract Remote limb ischemic post conditioning (RIPOC) has been reported to attenuate cerebral ischemic reperfusion (I/R) injury, while the molecular mechanisms remain elusive. Various studies have highlighted the involvement of glycogen synthase kinase (GSK‐3&bgr;) in…
read more here.
Keywords:
reperfusion;
gsk bgr;
injury;
creb bdnf ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "European Journal of Pharmacology"
DOI: 10.1016/j.ejphar.2017.10.027
Abstract: ABSTRACT Chronic cerebral hypofusion (CCH) promotes hyperphosphorylation of tau proteins, a key neuropathological trait that reflects neurodegenerative disorders. Nimodipine, an L‐type calcium channel antagonist, has been reported to show neuroprotective effects. In this study, we…
read more here.
Keywords:
tau phosphorylation;
gsk bgr;
phosphorylation ser396;
mir 132 ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "International Immunopharmacology"
DOI: 10.1016/j.intimp.2018.12.042
Abstract: ABSTRACT The nod‐like receptor protein 3 (NLRP3) inflammasome has a critical role in cerebral ischemic injury, and autophagy is related to activation of the inflammasome under oxidative stress conditions. However, it is unclear how NLRP3…
read more here.
Keywords:
bgr;
activation;
nlrp3 inflammasome;
gsk bgr ... See more keywords